IDNA ETF

IDNA ETF
$41.28
See how much of IDNA you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
+8.22%
3 Months
+26.00%
6 Months
+46.85%
YTD
+61.50%
1 Year
+79.25%
3 Years (annualized)
+20.25%
5 Years (annualized)
-6.14%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IDNA have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index(^NYFSGIB)
This ETF (YTD)
+61.50%
Peer Avg (YTD)
+8.76%
vs Peers
+52.74%

IDNA ETF Performance

IDNA performance across multiple time periods: 1-month 8.22%, YTD 61.50%, 1-year 79.25%, 3-year 20.25%, 5-year -6.14%.

IDNA returns outperform the peer average of 8.76% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IDNA vs another fund shows side-by-side returns. IDNA alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+8.22%N/A
3 Months+26.00%N/A
6 Months+46.85%N/A
1 Year+79.25%N/A
3 Years+20.25%N/A
5 Years-6.14%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized